OOIR: Observatory of International Research

Papers

(The TQCC of Rheumatic Disease Clinics of North America is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Copyright	115
Contents	104
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	64
The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network	45
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	34
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	33
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	27
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	25
Osteoarthritis Treatment Guidelines from Six Professional Societies	21
Copyright	18
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	17
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	15
Forthcoming Issues	15
COPA Syndrome from Diagnosis to Treatment	14
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	14
The Short and Long of COVID-19	13
Contributors	13
Lessons Learned from the COVID-19 Pandemic in Rheumatology	13
Taxonomy of Quality of Care Indicators	13
Copyright	12
Imaging Challenges and Developments in Large-vessel Vasculitis	12
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	12
Pulmonary Hypertension Associated with Connective Tissue Disease	11
De novo Connective Tissue Disorders as Immune-related Adverse Events	11
Contributors	11

Contents	10
It Takes Oysters to Generate Pearls	9
Copyright	9
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	9
Vaccinations in Patients with Rheumatic Disease	9
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	8
Daniel J McCarty, MD: A Giant of Rheumatology	8
COVID-19 and Rheumatology	8
Primary Cardiac Involvement in Systemic Sclerosis	8
Expanding the Treatment Team	8
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	8
Newer Immunosuppressants for Rheumatologic Disease	8
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	8
Charles L Christian	8
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	7
Rheumatology Pearls for the Primary Care Physician	7
Preventative Care in Scleroderma	7
Scleroderma: Best Approaches to Patient Care	7
E Carwile LeRoy, MD	6
Contributors	6
Guideline Development and Implementation in Rheumatic Disease	6
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	6
Cardiac MRI in Rheumatic Disease	6
Copyright	6
The Challenges of New Biologic Therapies in Pediatrics	6
Imaging of the Major Salivary Glands in Rheumatic Disease	6
Contents	6
Imaging of Pulmonary Manifestations of Connective Tissue Disease	6
Sustainable Health Care and Advocacy for Rheumatologists	6
A Guide to Contemporary Clinical Practice Guidelines	6
The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies	6
Contributors	5
Heart Failure in Rheumatic Disease	5
Forthcoming Issues	5
Myositis	5
Contents	5
Copyright	5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	5
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	5
Beyond Coronary Artery Disease	5
Impacts of Storms, Precipitation, Drought, and Water Quality on Rheumatic Diseases	5
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	4
Copyright	4
SARS-CoV-2 Infection and COVID-19 in Children	4
Treatment Guidelines in Gout	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
Genetic Defects in Early-Onset Inflammatory Bowel Disease	4
Emerging and Expanding Infections due to Climate Change of Concern to Rheumatologists	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4

Management and Cure of Gouty Arthritis	4
Dual-Energy Computed Tomography Applications in Rheumatology	4
Ambient PM2.5 Exposure and the Incidence of Systemic Lupus Erythematosus	3
Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica	3
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis	3
Impact of Climate Change on Rheumatology Care	3
Achieving Precision Medicine in Psoriatic Arthritis	3
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	3
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	3
Forthcoming Issues	3
Health Care Utilization	3
Interstitial Lung Disease	3
Expanding IPEX: Inborn Errors of Regulatory T Cells	3
Contents	3
The Role of Psychology in Pediatric Rheumatic Diseases	3
The Effects of Extreme Heat on Individuals with Rheumatic Conditions	3
Imaging in Inflammatory Bowel Disease	3